To include your compound in the COVID-19 Resource Center, submit it here.

Melinta goes public by acquiring majority of Cempra

Melinta Therapeutics Inc. (New Haven, Conn.) has found a path to becoming public by acquiring a majority stake of fellow infectious company Cempra Inc. (NASDAQ:CEMP). The combined

Read the full 271 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE